130 related articles for article (PubMed ID: 16258785)
1. [Cost-effectiveness of prevention of coronary disease in Germany].
Lauterbach KW; Gerber A; Klever-Deichert G; Stollenwerk B
Z Kardiol; 2005; 94 Suppl 3():III/100-4. PubMed ID: 16258785
[TBL] [Abstract][Full Text] [Related]
2. [Primary prevention of coronary heart disease? What is cost effective in the clinical practice?].
Kübler W
Z Kardiol; 2005; 94 Suppl 3():III/92-9. PubMed ID: 16258799
[TBL] [Abstract][Full Text] [Related]
3. [Primary prevention-psychosocial aspects].
Albus C; Siegrist J
Z Kardiol; 2005; 94 Suppl 3():III/105-12. PubMed ID: 16258786
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of coronary artery disease].
Sandri M; Gielen S; Schuler G
Internist (Berl); 2008 Feb; 49(2):154-61. PubMed ID: 18214410
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery disease.
Von Schacky C
Dtsch Med Wochenschr; 2002 Nov; 127(46):2429-31. PubMed ID: 12432482
[TBL] [Abstract][Full Text] [Related]
7. [Cost-effectiveness of coronary heart disease prevention].
Wendland G; Klever-Deichert G; Lauterbach K
Z Kardiol; 2002; 91 Suppl 2():49-60. PubMed ID: 12436765
[TBL] [Abstract][Full Text] [Related]
8. [Primary prevention of coronary artery disease: is there a role for risk scores?].
Gohlke H
Herz; 2012 Feb; 37(1):75-80. PubMed ID: 22127743
[TBL] [Abstract][Full Text] [Related]
9. [Check-up-examinations in internal medicine].
Hunziker S; Hengstler P; Zimmerli L; Battegay M; Battegay E
Internist (Berl); 2006 Jan; 47(1):55-65, quiz 66-7. PubMed ID: 16365764
[TBL] [Abstract][Full Text] [Related]
10. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy.
Ess SM; Szucs TD
Ital Heart J; 2001 Mar; 2(3):181-8. PubMed ID: 11305529
[TBL] [Abstract][Full Text] [Related]
11. Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting.
Birim Ö; Bogers AJ; Kappetein AP
J Cardiovasc Surg (Torino); 2012 Oct; 53(5):641-50. PubMed ID: 22252542
[TBL] [Abstract][Full Text] [Related]
12. [Polish forum for prevention guidelines on cardiovascular risk assessment].
Podolec P; Kopeć G; Pajak A; Undas A; Kozek E; Tykarski A; Naruszewicz M; Stańczyk J; Opala G; Godycki-Cwirko M; Rynkiewicz A; Torbicki A; Musiał J
Kardiol Pol; 2007 Jan; 65(1):100-4. PubMed ID: 17295170
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
[TBL] [Abstract][Full Text] [Related]
14. [Individual coronary heart disease risk prediction as part of primary prevention].
Bershteĭn LL; Katamadze NO; Laznam SS; Grishkin IuN
Kardiologiia; 2012; 52(10):65-74. PubMed ID: 23098353
[TBL] [Abstract][Full Text] [Related]
15. Lessons from curbing the coronary artery disease epidemic for confronting the impending epidemic of heart failure.
Kannel WB
Med Clin North Am; 2004 Sep; 88(5):1129-33, ix. PubMed ID: 15331309
[TBL] [Abstract][Full Text] [Related]
16. Reducing the burden of coronary artery disease in India: challenges and opportunities.
Enas EA; Singh V; Munjal YP; Bhandari S; Yadave RD; Manchanda SC
Indian Heart J; 2008; 60(2):161-75. PubMed ID: 19218731
[TBL] [Abstract][Full Text] [Related]
17. [In focus: adiposity].
Kessler R
Internist (Berl); 2006 Aug; 47(8):871; author reply 871. PubMed ID: 16998961
[No Abstract] [Full Text] [Related]
18. [In focus: adiposity]].
Klauser A
Internist (Berl); 2006 Aug; 47(8):870; author reply 870-1. PubMed ID: 16998960
[No Abstract] [Full Text] [Related]
19. [Possible ways of managing cardiovascular prevention: polypharmacy, additional payment or application of evidence based medicine?].
Gohlke H
Internist (Berl); 2005 Jun; 46(6):698-705. PubMed ID: 15830173
[TBL] [Abstract][Full Text] [Related]
20. [Are bonus systems applicable to guideline-oriented depression treatment provided by general practitioners and neurologists?].
Schneider F; Menke R; Härter M; Salize HJ; Janssen B; Bergmann F; Berger M; Gaebel W
Nervenarzt; 2005 Mar; 76(3):308-14. PubMed ID: 15007509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
